Determinants of universal adolescent hepatitis B vaccine uptake

被引:22
作者
Wallace, LA
Bramley, JC
Ahmed, S
Duff, R
Hutchinson, SJ
Carman, WF
Kitchin, NRE
Goldberg, DJ
机构
[1] Scottish Ctr Infect & Environm Hlth, Glasgow G3 7LN, Lanark, Scotland
[2] Univ Glasgow, Glasgow G12 8RZ, Lanark, Scotland
[3] Greater Glasgow NHS Board, Glasgow G3 8YU, Lanark, Scotland
[4] Yorkhill NHS Trust, Southbank Ctr, Sch Hlth Serv, Glasgow G5 0RE, Lanark, Scotland
[5] Gartnavel Royal Hosp, W Scotland Specialist Virol Ctr, Glasgow G12 0ZA, Lanark, Scotland
[6] Aventis Pasteur MSD, Maidenhead SL6 1QP, Berks, England
关键词
D O I
10.1136/adc.2003.043687
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
The UK is currently considering the introduction of universal hepatitis B vaccination. This study of determinants of vaccine uptake among school based adolescents shows that living in areas of high deprivation, commonly associated with injecting drug risk behaviours, was the most important factor, with statistically significant lower odds of receiving three doses. This was less pronounced for receipt of two doses. Thus, there are implications for future policy; if universal vaccination is approved, a licensed two dose schedule would be most appropriate in this setting.
引用
收藏
页码:1041 / 1042
页数:2
相关论文
共 7 条
[1]  
Bramley J C, 2002, Commun Dis Public Health, V5, P318
[2]   A randomized trial of alternative two- and three-dose hepatitis B vaccination regimens in adolescents: Antibody responses, safety, and immunologic memory [J].
Cassidy, WM ;
Watson, B ;
Ioli, VA ;
Williams, K ;
Bird, S ;
West, DJ .
PEDIATRICS, 2001, 107 (04) :626-631
[3]  
Centers for Disease C Prevention, 2003, MMWR-MORBID MORTAL W, V52, P868
[4]   Factors associated with student participation in a school-based hepatitis B immunization program [J].
Goldstein, ST ;
Cassidy, WM ;
Hodgson, W ;
Mahoney, FJ .
JOURNAL OF SCHOOL HEALTH, 2001, 71 (05) :184-187
[5]  
Lamagni T L, 2001, Commun Dis Public Health, V4, P71
[6]  
MCLOONE P, 2000, CARSTAIRS SCORES SCO
[7]  
Stevenson J, 2001, Commun Dis Public Health, V4, P60